• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Echo Therapeutics Inc

+ Add to Watchlist

ECTE:US

1.5000 USD 0.00000.00%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Echo Therapeutics Inc (ECTE)

Open: 1.5000 Day's Range: 1.5000 - 1.6100 Volume: 43,476
Previous Close: 1.5000 52wk Range: 0.3900 - 4.1300 1-Yr Rtn: -52.38%

Stock Chart for ECTE

No chart data available.
  • ECTE:US 1.5000
  • 1D
  • 1M
  • 1Y
1.5000
Interactive ECTE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECTE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3621
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 18.95
Shares Outstanding (M) 12.63
30 Day Average Volume 94,902
Price/Book (mrq) 1.7707
Price/Sale (ttm) 177.5388
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECTE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ECTE

Echo Therapeutics Inc. is a specialty transdermal therapeutics and diagnostics company. The Company develops portfolio of topical formulations of established, FDA approved products using its proprietary Azone dermal penetration technology.

Robert F Doman "Bob"ChairmanScott W HollanderChief Executive Officer
Kenneth Gary "Ken"Senior VP:Rsch & OpsDaniel Sunday "Dan"VP:Manufacturing & Global Supply Chain
More Company Profile & Key Executives for ECTE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • ECTE News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil